Czech National Bank Increases Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Czech National Bank increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 15.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 93,026 shares of the company’s stock after buying an additional 12,147 shares during the period. Czech National Bank’s holdings in GE HealthCare Technologies were worth $8,730,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Handelsbanken Fonder AB increased its position in shares of GE HealthCare Technologies by 1.0% during the third quarter. Handelsbanken Fonder AB now owns 163,691 shares of the company’s stock worth $15,362,000 after acquiring an additional 1,557 shares during the last quarter. Wright Investors Service Inc. increased its holdings in GE HealthCare Technologies by 124.8% during the 3rd quarter. Wright Investors Service Inc. now owns 12,344 shares of the company’s stock worth $1,158,000 after purchasing an additional 6,853 shares during the last quarter. Quent Capital LLC raised its position in shares of GE HealthCare Technologies by 18.4% in the 3rd quarter. Quent Capital LLC now owns 766 shares of the company’s stock valued at $72,000 after purchasing an additional 119 shares in the last quarter. Park Avenue Securities LLC boosted its stake in shares of GE HealthCare Technologies by 38.8% during the 3rd quarter. Park Avenue Securities LLC now owns 4,058 shares of the company’s stock valued at $381,000 after buying an additional 1,135 shares during the last quarter. Finally, Farmers Trust Co. acquired a new stake in shares of GE HealthCare Technologies during the third quarter worth approximately $221,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Trading Up 0.1 %

Shares of GEHC opened at $90.77 on Thursday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.55. The stock has a market cap of $41.43 billion, a PE ratio of 26.54, a P/E/G ratio of 3.40 and a beta of 1.18. The stock’s 50-day moving average is $86.69 and its two-hundred day moving average is $83.33.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The firm had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. GE HealthCare Technologies’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.92 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of several recent analyst reports. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price target for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. started coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective on the stock. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a report on Wednesday, September 18th. Finally, Evercore ISI increased their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.23.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.